![Ron Bentsur](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ron Bentsur
Chief Executive Officer at
NUVECTIS PHARMA, INC.
Net worth: 36 M $ as of 30/05/2026
Profile
Ronald E.
Bentsur is the founder of Nuvectis Pharma, Inc., founded in 2020, where the title held is Chairman, President & Chief Executive Officer.
Current jobs include Chairman at Ait Ltd. since 2015, Director at Beyond Air Ltd. since 2017, and Venture Advisor at Israel Biotech Fund.
Former jobs include Chief Executive Officer at XTL Biopharmaceuticals Ltd. from 2006 to 2009, Chief Executive Officer & Director at UroGen Pharma Ltd. from 2015 to 2019, Chief Executive Officer & Director at Keryx Biopharmaceuticals, Inc. from 2009 to 2015, Director at Stemline Therapeutics, Inc. from 2009 to 2020, Director-Technology Investment Banking at Leumi Partners Underwriters Ltd. from 1998 to 2000, Director at Nextgen Biomed Ltd., and Independent Director at Beyond Air, Inc. from 2015 to 2025.
Education includes undergraduate studies at The Hebrew University of Jerusalem and an MBA from The Leonard N Stern School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NUVECTIS PHARMA, INC. 13.91% | 29/06/2026 | 3,688,424 ( 13.91% ) | 36 M $ | 30/05/2026 |
Ron Bentsur active positions
| Companies | Position | Start |
|---|---|---|
| NUVECTIS PHARMA, INC. | Chief Executive Officer | 26/07/2020 |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Operates as a clinical-stage medical device and biopharmaceutical company | Director/Board Member | 31/12/2016 |
Ait Ltd.
 Ait Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Chairman | 31/07/2015 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Former positions of Ron Bentsur
| Companies | Position | End |
|---|---|---|
| BEYOND AIR, INC. | Director/Board Member | 13/03/2025 |
| STEMLINE THERAPEUTICS, INC. | Director/Board Member | 31/05/2020 |
| UROGEN PHARMA LTD. | Chief Executive Officer | 02/01/2019 |
| KERYX BIOPHARMACEUTICALS | Chief Executive Officer | 29/04/2015 |
| XTL BIOPHARMACEUTICALS LTD. | Chief Executive Officer | 31/03/2009 |
Training of Ron Bentsur
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
50
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
XTL Biopharmaceuticals Ltd.
 XTL Biopharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops pharmaceutical drugs for the treatment of autoimmune diseases | Health Technology |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leumi Partners Underwriters Ltd. | |
Nextgen Biomed Ltd.
 Nextgen Biomed Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures skin diseases pharmaceutical products | Health Technology |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beyond Air, Inc.
 Beyond Air, Inc. Medical SpecialtiesHealth Technology Developing a platform of nitric oxide generators and delivery systems | Health Technology |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Operates as a clinical-stage medical device and biopharmaceutical company | Health Technology |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Ait Ltd.
Ait Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Ron Bentsur
Choose MarketScreener 
